Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Kenyon

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Bone Marrow Transplantation|September 28, 2019
Full donor chimerism without graft-versus-host disease: the key factor for maximum benefit of pre-emptive donor lymphocyte infusions (pDLI)Jesus Feliu, Victoria Potter, Francesco Grimaldi, et al.
Bone Marrow Transplantation|November 14, 2022
Sexual function of adult long-term survivors and their partners after allogeneic hematopoietic cell transplantation in Europe (S-FAST): a study from the Transplant Complications Working Party and Nurses Group of the EBMTLars Klingen Gjærde, Corien Eeltink, Jacqui Stringer, et al.
Frontiers in Oncology|July 30, 2019
Differential Interaction of Peripheral Blood Lymphocyte Counts (ALC) With Different <i>in vivo</i> Depletion Strategies in Predicting Outcomes of Allogeneic Transplant: An International 2 Center ExperienceVipul Sheth, Vanessa Kennedy, Hugues de Lavallade, et al.
Bone Marrow Transplantation|March 27, 2023
Practice harmonization workshops of EBMT: an expert-based approach to generate practical and contemporary guidelines within the arena of hematopoietic cell transplantation and cellular therapyIbrahim Yakoub-Agha, Raffaella Greco, Francesco Onida, et al.
Frontiers in Transplantation|July 12, 2024
Systematic screening and focused evaluation for veno-occlusive disease/sinusoidal obstructive syndrome (VOD/SOS) following allogeneic stem cell transplant is associated with earlier diagnosis and prompt institution of defibrotide treatmentDaniele Avenoso, Michelle Kenyon, Varun Mehra, et al.
Bone Marrow Transplantation|June 18, 2024
Patient engagement in hematopoietic stem cell transplantation and cell therapy: a survey by the EBMT patient engagement task force & transplantation complications working partyHélène Schoemans, Linda J Burns, Sarah J Liptrott, et al.
Transplantation and Cellular Therapy|August 14, 2023
Myeloablative Dose of Busulfan and Fludarabine Combined with In Vivo T Cell Depletion Is Safe and Effective Conditioning for Acute Myeloid Leukemia and Myelodysplastic Syndrome PatientsDaniele Avenoso, Varun Mehra, Liron Barnea Slonim, et al.
Regulatory Toxicology and Pharmacology : RTP|May 31, 2023
Acceptable intakes (AIs) for 11 small molecule N-nitrosamines (NAs)Joel P Bercu, Melisa Masuda-Herrera, Alejandra Trejo-Martin, et al.
Environmental and Molecular Mutagenesis|June 3, 2024
Severity of effect considerations regarding the use of mutation as a toxicological endpoint for risk assessment: A report from the 8th International Workshop on Genotoxicity Testing (IWGT)Barbara L Parsons, Marc A Beal, Kerry L Dearfield, et al.
Bone Marrow Transplantation|October 7, 2024
An international survey to better understand the current incidence, severity, and management of VOD/SOSMarion Larue, Myriam Labopin, Eolia Brissot, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Bone Marrow Transplantation|September 28, 2019
Full donor chimerism without graft-versus-host disease: the key factor for maximum benefit of pre-emptive donor lymphocyte infusions (pDLI)Jesus Feliu, Victoria Potter, Francesco Grimaldi, et al.
Bone Marrow Transplantation|November 14, 2022
Sexual function of adult long-term survivors and their partners after allogeneic hematopoietic cell transplantation in Europe (S-FAST): a study from the Transplant Complications Working Party and Nurses Group of the EBMTLars Klingen Gjærde, Corien Eeltink, Jacqui Stringer, et al.
Frontiers in Oncology|July 30, 2019
Differential Interaction of Peripheral Blood Lymphocyte Counts (ALC) With Different <i>in vivo</i> Depletion Strategies in Predicting Outcomes of Allogeneic Transplant: An International 2 Center ExperienceVipul Sheth, Vanessa Kennedy, Hugues de Lavallade, et al.
Bone Marrow Transplantation|March 27, 2023
Practice harmonization workshops of EBMT: an expert-based approach to generate practical and contemporary guidelines within the arena of hematopoietic cell transplantation and cellular therapyIbrahim Yakoub-Agha, Raffaella Greco, Francesco Onida, et al.
Frontiers in Transplantation|July 12, 2024
Systematic screening and focused evaluation for veno-occlusive disease/sinusoidal obstructive syndrome (VOD/SOS) following allogeneic stem cell transplant is associated with earlier diagnosis and prompt institution of defibrotide treatmentDaniele Avenoso, Michelle Kenyon, Varun Mehra, et al.
Bone Marrow Transplantation|June 18, 2024
Patient engagement in hematopoietic stem cell transplantation and cell therapy: a survey by the EBMT patient engagement task force & transplantation complications working partyHélène Schoemans, Linda J Burns, Sarah J Liptrott, et al.
Transplantation and Cellular Therapy|August 14, 2023
Myeloablative Dose of Busulfan and Fludarabine Combined with In Vivo T Cell Depletion Is Safe and Effective Conditioning for Acute Myeloid Leukemia and Myelodysplastic Syndrome PatientsDaniele Avenoso, Varun Mehra, Liron Barnea Slonim, et al.
Regulatory Toxicology and Pharmacology : RTP|May 31, 2023
Acceptable intakes (AIs) for 11 small molecule N-nitrosamines (NAs)Joel P Bercu, Melisa Masuda-Herrera, Alejandra Trejo-Martin, et al.
Environmental and Molecular Mutagenesis|June 3, 2024
Severity of effect considerations regarding the use of mutation as a toxicological endpoint for risk assessment: A report from the 8th International Workshop on Genotoxicity Testing (IWGT)Barbara L Parsons, Marc A Beal, Kerry L Dearfield, et al.
Bone Marrow Transplantation|October 7, 2024
An international survey to better understand the current incidence, severity, and management of VOD/SOSMarion Larue, Myriam Labopin, Eolia Brissot, et al.
Pageof 5